Product news from the 05/22/07 news brief
Merck announced that the FDA has approved a new dosage of Fosamax Plus D (alendronate sodium/cholecalciferol).
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.